cyclosporine has been researched along with Cirrhoses, Experimental Liver in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliazadeh, S; Alizadeh, AM; Amiriani, T; Dehpour, A; Enayati, A; Ensan, PS; Jafarzadeh, F; Jand, Y; Khori, V; Mazaheri, Z; Moheimani, HR; Pourabouk, M; Pourkhani, AH; Rajaei, M; Shakiba, D; Zeyghami, MA | 1 |
| Dorn, C; Hellerbrand, C; Ledermann, M; Patsenker, E; Saegesser, H; Schneider, V; Stickel, F | 1 |
| Jia, J; Wang, H; Wang, T; You, H; Zhang, Y | 1 |
| Bach, M; Brunner, G; Kroeger, T; Lie, TS; Ogawa, K; Preissinger, H; Vogel, J | 1 |
4 other study(ies) available for cyclosporine and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Preconditioning and anti-apoptotic effects of Metformin and Cyclosporine-A in an isolated bile duct-ligated rat heart.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Apoptosis Regulatory Proteins; Bile Ducts; Cardiomyopathies; Cyclosporine; Cytoprotection; Enzyme Activation; Hemodynamics; Ischemic Preconditioning, Myocardial; Isolated Heart Preparation; Ligation; Liver Cirrhosis, Experimental; Male; Metformin; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats, Wistar; Signal Transduction | 2021 |
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
Topics: Animals; Bile Ducts; Calcineurin Inhibitors; Cyclosporine; Disease Progression; Everolimus; Fatty Liver; Immunosuppressive Agents; Ligation; Liver Cirrhosis, Experimental; Male; Matrix Metalloproteinases; Non-alcoholic Fatty Liver Disease; Portal Pressure; Rats; Rats, Wistar; RNA, Messenger; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Triglycerides | 2011 |
N-methyl-4-isoleucine cyclosporine attenuates CCl -induced liver fibrosis in rats by interacting with cyclophilin B and D.
Topics: Actins; Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Cell Line; Collagen Type III; Cyclophilins; Cyclosporine; Cytoprotection; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Hydroxyproline; Liver; Liver Cirrhosis, Experimental; Male; Matrix Metalloproteinase 13; Peptidyl-Prolyl Isomerase F; Rats; Rats, Wistar; RNA Interference; RNA, Messenger; Serum Albumin; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta | 2011 |
The protective effect of cyclosporine against cirrhotic alteration of the liver.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Body Weight; Carbon Tetrachloride Poisoning; Collagen; Cyclosporine; Liver; Liver Cirrhosis, Experimental; Male; Rats; Rats, Inbred Strains | 1991 |